Janux Therapeutics Inc (JANX) Stock Price, Quote, News & History

JANXNASDAQ
$16.12
0.120.75%
At close: Aug 14, 5:00 PM EST
$16.12
N/A
After Hours: 4:00 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-41.25M
Investing Cash Flow (TTM)
7.35M
Financing Cash Flow (TTM)
9.22M
Free Cash Flow (TTM)
-41.93M
Capital Expenditure (TTM)
-674.00K
Net Change in Cash (TTM)
-24.68M

Analyst Trends and Forecast

2
Feb
1
1
1
Apr
3
May
1
Jun
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$28.27M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
41.63
PB Ratio (TTM)
1.05
Earnings Yield % (TTM)
-10.25%
Earnings Yield % (FWD)
-10.56%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$15.18

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$27.77M
Debt to Equity
0.02
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$16.00
Close
$16.12
Volume / Avg.
441.52K / 1.03M
Day Range
$15.71 - $16.22
52 Wk Range
12.12 - 35.34
Market Cap
$985.52M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
54
Short Interest
12.4%
Days to Cover
7.74

About

Sector
Health Care
Industry
Biotechnology
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Janux Therapeutics (JANX) stock?

A

You can purchase shares of Janux Therapeutics (NASDAQ:JANX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Janux Therapeutics (JANX) competitors?

Q

What is the forecast, or price target, for Janux Therapeutics (JANX) stock?

A

Janux Therapeutics has a consensus price target of $48.74.

Q

What is the current price for Janux Therapeutics (JANX)?

A

The stock price for Janux Therapeutics (NASDAQ: JANX) is $16.12 last updated August 14, 2026 at 4:00 PM EDT.

Q

Does Janux Therapeutics (JANX) pay a dividend?

A

There are no upcoming dividends for Janux Therapeutics.

Q

When is Janux Therapeutics (NASDAQ:JANX) reporting earnings?

A

Janux Therapeutics does not have any upcoming earnings scheduled.

Q

Is Janux Therapeutics (JANX) going to split?

A

There is no upcoming split for Janux Therapeutics.

Q

What sector and industry does Janux Therapeutics (JANX) operate in?

A

Janux Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.